ArticleAntibiotics (Basel, Switzerland)2022

Bioengineered Nisin A Derivatives Display Enhanced Activity against Clinical Neonatal Pathogens.

Anna Desmond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.